Download PDF
Radiologie up2date 2012; 12(03): 251-263
DOI: 10.1055/s-0032-1309848
Interventionelle Radiologie
© Georg Thieme Verlag KG Stuttgart · New York

Myomembolisation – State of the Art

Uterine artery embolisation – state of the art
T. J. Kröncke
Further Information

Publication History

Publication Date:
05 September 2012 (online)

Also available at
    Permissions and Reprints All articles of this category

Zusammenfassung

Die Myomembolisation ist ein sicheres und effektives minimalinvasives Verfahren zur Therapie des symptomatischen Uterus myomatosus. Sie erweitert das therapeutische Spektrum und ist insbesondere für Frauen mit abgeschlossener Familienplanung und Wunsch nach einem gebärmuttererhaltenden nicht operativen Verfahren geeignet.

Abstract

Symptomatic leiomyomata of the uterus (Fibroids) represent a major health problem in premopausal women and are the leading indication for hysterectomy in Germany. Uterine artery embolisation (UAE) has emerged as a uterine-sparing treatment alternative for women wishing to retain their uterus. A high clinical success rate of UAE to control fibroid related symptoms and improve quality-of-life as well as a low complication rate has been reported in the literature over the last 10 years. This article provides an overview on UAE for uterine fibroids.

Keywords

Uterus - leiomyoma - fibroids - uterine artery embolisation - quality-of-life - MRI - review
 

  • Literatur

  • 1 Day Baird D, Dunson DB, Hill MC et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003; 188: 100-107
    CrossrefPubMedGoogle Scholar
  • 2 Gupta S, Jose J, Manyonda I. Clinical presentation of fibroids. Best Practice & Research Clinical Obstetrics & Gynaecology 2008; 22: 615-626
    CrossrefPubMedGoogle Scholar
  • 3 Kröncke T, David M. Uterine artery embolization (UAE) for myoma treatment-results of the 3rd radiologic gynecologic expert meeting. Rofo 2010; 182: 615-617
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Spies JB, Myers ER, Worthington-Kirsch R et al. The FIBROID Registry: symptom and quality-of-life status 1 year after therapy. Obstet Gynecol 2005; 106: 1309-1318
    CrossrefPubMedGoogle Scholar
  • 5 Smeets AJ, Nijenhuis RJ, Boekkooi PF et al. Safety and effectiveness of uterine artery embolization in patients with pedunculated fibroids. J Vasc Interv Radiol 2009; 20: 1172-1175
    CrossrefPubMedGoogle Scholar
  • 6 Scheurig-Muenkler C, Poellinger A, Wagner M et al. Ovarian Artery Embolization in Patients With Collateral Supply to Symptomatic Uterine Leiomyomata. Cardiovasc Intervent Radiol 2011; 34: 1199-1207
    CrossrefPubMedGoogle Scholar
  • 7 Hu NN, Kaw D, McCullough MF et al. Menopause and menopausal symptoms after ovarian artery embolization: a comparison with uterine artery embolization controls. J Vasc Interv Radiol 2011; 22: 710-715
    CrossrefPubMedGoogle Scholar
  • 8 Mara M, Maskova J, Fucikova Z et al. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology 2008; 31: 73-85
    CrossrefPubMedGoogle Scholar
  • 9 Omary RA, Vasireddy S, Chrisman HB et al. The Effect of Pelvic MR Imaging on the Diagnosis and Treatment of Women with Presumed Symptomatic Uterine Fibroids. J Vasc Interv Radiol 2002; 13: 1149-1153
    CrossrefPubMedGoogle Scholar
  • 10 Rajan DK, Margau R, Kroll RR et al. Clinical utility of ultrasound versus magnetic resonance imaging for deciding to proceed with uterine artery embolization for presumed symptomatic fibroids. Clin Radiol 2011; 66: 57-62
    CrossrefPubMedGoogle Scholar
  • 11 Spielmann AL, Keogh C, Forster BB et al. Comparison of MRI and sonography in the preliminary evaluation for fibroid embolization. AJR Am J Roentgenol 2006; 187: 1499-1504
    CrossrefPubMedGoogle Scholar
  • 12 Galvez JA, McCarthy S, Weinreb J et al. Comparison of MRI outcomes of uterine artery embolization for uterine leiomyoma using tris-acryl gelatin microspheres, polyvinyl alcohol spheres, and polyvinyl alcohol particles. J Comput Assist Tomogr 2008; 32: 356-361
    CrossrefPubMedGoogle Scholar
  • 13 Kroencke TJ, Scheurig C, Lampmann LE et al. Acrylamido polyvinyl alcohol microspheres for uterine artery embolization: 12-month clinical and MR imaging results. J Vasc Interv Radiol 2008; 19: 47-57
    CrossrefPubMedGoogle Scholar
  • 14 Vorwerk D, Rosen T, Keller E et al. Evolution of inflammatory parameters after fibroid embolization. Rofo 2003; 175: 253-257
    Article in Thieme ConnectPubMedGoogle Scholar
  • 15 Spies JB, Spector A, Roth AR et al. Complications after uterine artery embolization for leiomyomas. Obstet Gynecol 2002; 100: 873-880
    CrossrefPubMedGoogle Scholar
  • 16 Scheurig-Muenkler C, Lembcke A, Froeling V et al. Uterine artery embolization for symptomatic fibroids: long-term changes in disease-specific symptoms and quality of life. Human Reproduction 2011; 36: 2036-2042
    PubMedGoogle Scholar
  • 17 van der Kooij SM, Hehenkamp WJK, Volkers NA et al. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology 2010; 203: 105-1-q3
    PubMedGoogle Scholar
  • 18 Spies JB, Bruno J, Czeyda-Pommersheim F et al. Long-term outcome of uterine artery embolization of leiomyomata. Obstet Gynecol 2005; 106: 933-939
    CrossrefPubMedGoogle Scholar
  • 19 Moss JG, Cooper KG, Khaund A et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results. BJOG: An International Journal of Obstetrics & Gynaecology 2011; 118: 936-944
    CrossrefPubMedGoogle Scholar